Possible risk for re-colonization with methicillin-resistant Staphylococcus aureus (MRSA) by faecal transmission

Martina Klotz1, Stefan Zimmermann, Sandra Opper

  • 1Institute of Medical Microbiology and Hygiene, Philipps-University Marburg, Pilgrimstein 2, D-35037 Marburg, Germany.

Insights

Gastrointestinal colonization with methicillin-resistant Staphylococcus aureus (MRSA) is common and may cause re-infection. This study suggests MRSA in stool samples is a significant, unrecognized transmission source, impacting patient decontamination strategies.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Hospital Epidemiology

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a growing cause of hospital-acquired infections globally.
  • Standard decontamination protocols often fail, leading to persistent or recurrent MRSA colonization in patients.

Purpose of the Study:

  • To investigate if undetected gastrointestinal colonization contributes to MRSA persistence and re-colonization.
  • To explore the role of the gastrointestinal tract as a reservoir for MRSA transmission.

Main Methods:

  • Collected MRSA strains from 290 hospitalized patients over two years.
  • Utilized pulsed-field gel electrophoresis (PFGE) for epidemiological analysis of MRSA isolates.
  • Examined MRSA presence in stool samples alongside other patient materials.

Main Results:

  • MRSA was isolated from stool samples in a significant proportion (24.1%) of all collected strains.
  • In 13.1% of cases, MRSA was initially detected in stool before identification elsewhere in the patient.
  • PFGE analysis identified distinct MRSA clones, with some stool isolates being indistinguishable from isolates from other body sites.

Conclusions:

  • Gastrointestinal tract colonization with MRSA is a significant factor in patient re-colonization and hospital-acquired infections.
  • MRSA in stool represents an unrecognized transmission route, necessitating revised decontamination and therapeutic strategies.
  • Findings suggest modifications to current hygienic practices for MRSA management are required.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mismatch Repair01:36

Mismatch Repair

Overview
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...